OncoLog, Volume 54, Number 10, October 2009 Page: Front Cover
This periodical is part of the collection entitled: Texas State Publications and was provided to The Portal to Texas History by the UNT Libraries Government Documents Department.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
TxD
Z US905.6 ON1 54:10
M. D. Anderson
Cancer Center
MAaking Cancer HistoryClinical Trials
Experimental therapies
available for testicular
cancerempass
Metastatic Rectal Cancer
Treatment sequence options
that maximize survivalHouse Call
Pancreatic
cancer symptoms and
treatments explained
Texas State Documents
Collectionnlc
REPORT TO PHYSICIANS
OCTOBER 2009 VOL. 54, NO. 10
)
Early Testicular Cancer
Strategies that mitigate the risk of recurrencehave boosted the long-term success of treatment.
By John LeBas
W hen testicular cancer is found
early-that is, when the tumor
is confined to the testicle-the
cancer is almost always curable.
In fact, patients treated at this disease stage
can typically expect to lead full lives with few
long-term effects from the cancer or its treat-
ment on their fertility or health.
NON-CIRCUL ATIh
_. .U OF NT LI BRA RIMuch of this success in curing testicular cancer has re-
sulted from treating potential metastasis of the primary tumor.
Physicians at The University of Texas M. D. Anderson Cancer
Center continue to refine treatment approaches for early-
stage testicular cancer to achieve an optimal outcome for
each patient.
"There have been significant advances in how chemo-
therapy, surgery, and radiation are integrated to produce an
optimal outcome for patients with early testicular tumors,"
said Lance C. Pagliaro, an associate professor in the Depart-
ment of Genitourinary Medical Oncology at The University
of Texas M. D. Anderson Cancer (Continued on page 2)J
i;
S.'
t.
f
f/t
Dr. Lance Pagliaro (left)
and nurse practitioner
William Osai discuss
the treatment plan for a
patient with testicular
cancer. Treatment of the
disease at its earliest stage
can usually be done in a
way that limits both recur-
rence risk and side effects,
Dr. Pagliaro said.TEE UNIVERSITY OF TEXAS
MDANDERSON
CANCER CENTER.t
wy -
U of NT Dep. Libraries
76203----I
F J"
.,, _ 4
},
1 A
_ ' z"zSF
,
tl . r
Upcoming Pages
Here’s what’s next.
Search Inside
This issue can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Periodical.
University of Texas M.D. Anderson Cancer Center. OncoLog, Volume 54, Number 10, October 2009, periodical, October 2009; Houston, Texas. (https://texashistory.unt.edu/ark:/67531/metapth903740/m1/1/: accessed April 26, 2024), University of North Texas Libraries, The Portal to Texas History, https://texashistory.unt.edu; crediting UNT Libraries Government Documents Department.